« Back to Record
Citation APA

Piccart-Gebhart, M., Pritchard, K., McCullough, A. A., Dolci, S., McFadden, E., Holmes, A. A., Tonghua, L., Eidtmann, H., Dinh, P., Di Cosimo, S., Harbeck, N., Holmes, E., Tjulandin, S., Im, Y. H., Huang, C. S., Diéras, V., Hillman, D. D., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Baselga, J., Boyle, F., Xu, B., Gomez, H., Suter, T., Gelber, R. R., Perez, E. A., de Azambuja, E., Dueck, A. A., Viale, G., Zujewski, J. A., Goldhirsch, A., & Armour, A. (2016). Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial. Journal of clinical oncology, 34(10), 1034-1042. doi:10.1200/JCO.2015.62.1797


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231566

Piccart-Gebhart, M., Pritchard, K., McCullough, A. A., Dolci, S., McFadden, E., Holmes, A. A., Tonghua, L., Eidtmann, H., Dinh, P., Di Cosimo, S., Harbeck, N., Holmes, E., Tjulandin, S., Im, Y. H., Huang, C. S., Diéras, V., Hillman, D. D., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Baselga, J., Boyle, F., Xu, B., Gomez, H., Suter, T., Gelber, R. R., Perez, E. A., de Azambuja, E., Dueck, A. A., Viale, G., Zujewski, J. A., Goldhirsch, A., & Armour, A. (2016). Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer: Results From the randomized phase III adjuvant lapatinib and/or trastuzumab treatment optimization trial. Journal of clinical oncology, 34(10), 1034-1042. doi:10.1200/JCO.2015.62.1797